UBS Lowers PT on Salesforce from $300 to $260, Keeps Neutral Rating on the Stock

Salesforce, Inc. (NYSE:CRM) is one of the 10 Most Promising Technology Stocks to Invest In. On August 18, UBS lowered the price target on Salesforce, Inc. (NYSE:CRM) from $300 to $260, keeping its Neutral rating on the stock.

Karl Keirstead from UBS made a downgrade in CRM’s price target, showing signs of caution. The integration of Informatica is expected to take time, with acceleration expected by FY2027. Moreover, the company suffers from issues in expanding its distribution capacity, which has been flat for the last two years.

The demand for Salesforce’s Agentforce is gaining traction. On August 21, Emergent, a solutions provider in the public sector for offering transformational technology strategies to Federal and State & Local customers, integrated Salesforce services and its Agentforce solutions into its active GSA contract.

Keirstead remains cautious yet sees the firm’s fundamentals as stable. Whereas, Citizens JMP analyst Patrick Walravens remains optimistic on Salesforce’s growth and has rated the stock Outperform with a $430 price target ahead of the company’s Q2 FY2025 results scheduled on September 3.

As of August 25, Salesforce, Inc.’s (NYSE:CRM) average price target of $350, based on analysts’ estimates, implies an upside of almost 41.20% from current levels.

Salesforce, Inc. (NYSE:CRM) is a cloud-based CRM company that is famous for its AI-powered platform, Agentforce.

While we acknowledge the potential of CRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.